Hudson Institute of Medical Research
Hudson Institute of Medical Research is an Australian not-for-profit medical research institute that conducts discovery science and translational research in inflammation, cancer, and women's and newborn health, operating from within the Monash Health Translation Precinct with an on-site Phase I–IV clinical trials centre and serving patients, clinicians, and the broader research community.
- Company typePrivate
- Founded2014
- HeadquartersClayton, Australia
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Hudson Institute of Medical Research does
Hudson Institute of Medical Research is an Australian not-for-profit medical research institute headquartered in Clayton, Victoria, at 27–31 Wright Street, co-located within the Monash Health Translation Precinct. It was formed in 2014 through the merger of the Monash Institute of Medical Research and Prince Henry's Institute of Medical Research, and is named after Professor Bryan Hudson AO. The institute employs 289 staff and mentors 153 Honours, Masters, and PhD students across 43 research groups, with scientists and students drawn from 29 countries. Its research portfolio spans three principal areas: Inflammation (including the National Centre for Inflammation Research, antimicrobial resistance, inflammatory bowel disease, and autoimmune disease), Cancer (ovarian, lung, childhood, pancreatic, stomach, and sarcoma), and Women's and Newborn Health (preterm birth, endometriosis, pelvic organ prolapse, and infertility). Supporting infrastructure includes the Translational Research Facility — connected by link bridge to Monash Medical Centre and Monash Children's Hospital — and an eight-bed, 21-chair clinical trials centre capable of running Phase I through Phase IV trials, alongside cell therapy and umbilical cord blood stem cell manufacturing capabilities, the RNAte RNA therapeutics platform, and the Primary Aldosteronism Centre of Excellence (PACE).
The institute operates under a not-for-profit model funded by three principal streams: competitive government research grants (NHMRC, ARC, MRFF, and the Victorian Medical Research Acceleration Fund), tax-deductible philanthropic donations (it is a registered ACNC charity and Deductible Gift Recipient), and commercialisation/licensing income from industry collaborations with bio-med and biotech companies. Research outputs are translated to patients through the Monash Health Translation Precinct partnership rather than through commercial product distribution. Governance is provided by a Board chaired by Dr Robert (Bob) Edgar AM, with Professor Elizabeth Hartland AM serving as Director and CEO since 2017, and Professor Eugine Yafele (Monash Health CEO) sitting as Board Observer. The institute also maintains international research collaborations, including with the University of Toronto and an international paediatric cancer consortium, and jointly established the Victorian Infection and Immunity Network (VIIN), which aggregates over 1,000 researchers across Victorian institutions.
Hudson Institute of Medical Research firmographics
Firmographics- Name
- Hudson Institute of Medical Research
- Legal name
- Hudson Institute of Medical Research
- Website
- https://hudson.org.au
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Hudson Institute of Medical Research is an Australian not-for-profit medical research institute that conducts discovery science and translational research in inflammation, cancer, and women's and newborn health, operating from within the Monash Health Translation Precinct with an on-site Phase I–IV clinical trials centre and serving patients, clinicians, and the broader research community.
- Ownership category
- akta.pro rank
Hudson Institute of Medical Research industry classification
Industry- Product category
- Medical Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industries
- Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA), Clinical Research & Trial Central Laboratories (HLAFAMAL), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where Hudson Institute of Medical Research is headquartered
LocationHeadquarters
- HQ city
- Clayton
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Hudson Institute of Medical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Research Grants and Funding: Government funding through NHMRC, ARC, MRFF grants as primary research funding source. Also receives Victorian Medical Research Acceleration Fund and other government health grants.
- Philanthropic Donations: Tax-deductible donations from individuals, families, and organizations supporting specific research areas or general institute operations.
- Commercialisation and Licensing: Industry collaborations and agreements for research and education with bio-med and biotech sector companies, maximising discoveries to create new treatments and services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Hudson Institute of Medical Research product offering
Product offeringCore offering
Hudson Institute of Medical Research is a not-for-profit medical research institute that conducts basic, translational, and clinical research focused on inflammation, cancer, and women's and newborn health. It operates a clinical trials centre, a translational research facility, and commercialises research outputs through licensing and industry partnerships. The institute was formed through the 2014 merger of the Monash Institute of Medical Research and Prince Henry's Institute.
Product overview
Hudson Institute of Medical Research operates as a unified research institute offering medical research services, clinical trials, technology platforms, and graduate education programs. The core portfolio spans discovery science and translational research in Inflammation (including antimicrobial resistance, IBD, flu, microbiome), Cancer (including ovarian, childhood, lung, pancreatic, stomach cancer), and Women's and Newborn Health (including preterm birth, endometriosis, pelvic organ prolapse). Key offerings include a Translational Research Facility with clinical trials centre, technology platforms, and business development/commercialisation support. The institute's Primary Aldosteronism Centre of Excellence provides specialised hypertension diagnosis and treatment services.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials Services
Quantifiable outcome
- 264 research publications annually
- +2 more outcomes
Companies that use Hudson Institute of Medical Research
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Hudson Institute of Medical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hudson Institute of Medical Research partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Monash HealthcoreHudson Institute is affiliated with Monash Health and is a key partner of the Monash Health Translation Precinct. This partnership enables direct translation of discoveries into patient care through Monash Medical Centre and Monash Children's Hospital.
- Monash UniversitycoreAffiliated partner with students predominantly enrolled through the School of Clinical Sciences at Monash Health. Director Professor Elizabeth Hartland also serves as Head of the Department of Molecular and Translational Science at Monash University. Students are enrolled through the Faculty of Medicine, Nursing and Health Sciences.
- Monash Children's HospitalcoreConnected via link bridge to the Translational Research Facility, providing crucial connection between child patients and new potential therapies developed at the institute.
- Victorian Infection and Immunity Network (VIIN)minorProfessor Hartland jointly established VIIN, which has a membership of more than 1,000 researchers representing all major research universities and organisations in Victoria.
- International paediatric cancer consortiumminorHudson Institute joined an international paediatric cancer consortium to advance childhood cancer research through global collaboration.
- University of TorontominorInternational collaboration strengthening research ties with University of Toronto for shared research programs.
- Baker Medical Research InstituteminorHistorical partnership connection through Professor Warwick Anderson AO's academic positions.
Scale indicators6 records
Recent moves7 records
Expansion highlights7 records
Hudson Institute of Medical Research competitors and assessment
Company assessmentDirect peers
- Peter MacCallum Cancer Centre: Specialist cancer research and treatment institute in Melbourne with hospital integration and translational research mandate. Overlaps with Hudson's cancer pillar and shares the Australian not-for-profit research institute model with hospital embedment.
- Garvan Institute of Medical Research: Major Sydney-based not-for-profit medical research institute affiliated with St Vincent's Hospital and UNSW, conducting genomic, cancer and immunological research. Comparable scale, translational model and disease focus areas (cancer, immunity).
- QIMR Berghofer Medical Research Institute: Queensland-based medical research institute with translational research focus spanning infectious disease, cancer and mental health. Comparable as a large Australian not-for-profit translational research institute competing for the same NHMRC/ARC funding pool.
- Harry Perkins Institute of Medical Research: Western Australian medical research institute affiliated with the University of Western Australia and Fiona Stanley Hospital, conducting translational research across cancer and chronic disease. Comparable structure and translational emphasis to Hudson.
- South Australian Health and Medical Research Institute (SAHMRI): Adelaide-based independent health and medical research institute embedded within the new Royal Adelaide Hospital precinct. Directly comparable to Hudson in its hospital-integrated translational research design and not-for-profit structure.
- Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's largest medical research institute, also a not-for-profit affiliated with the University of Melbourne and Royal Melbourne Hospital, conducting discovery and translational research across cancer, inflammation and infectious disease — directly comparable in structure, funding mix and translational mission to Hudson.
- Baker Heart and Diabetes Institute: Independent Australian medical research institute focused on cardiometabolic disease, with historical leadership ties to Hudson via Professor Warwick Anderson. Comparable as a not-for-profit research institute with hospital affiliations and grant-driven funding mix.
- Doherty Institute for Infection and Immunity: Melbourne-based infection and immunity research institute jointly hosted by the University of Melbourne and Royal Melbourne Hospital. Directly overlaps with Hudson's inflammation pillar and Professor Hartland's microbiology background, and competes for similar NHMRC funding.
- Centenary Institute: Sydney-based independent medical research institute affiliated with Royal Prince Alfred Hospital and the University of Sydney, focused on cancer, inflammation and cardiovascular disease. Closely comparable in size, structure and research domain to Hudson.
Emerging players
- Children's Medical Research Institute (CMRI): Westmead-based independent medical research institute focused on childhood cancer, genetic diseases and gene therapy. Partially comparable to Hudson's paediatric cancer research, cell therapy and women's/newborn health focus areas, though smaller in translational scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Hudson Institute of Medical Research social profiles
Digital presenceHudson Institute of Medical Research compliance and trust
Trust signalCompliance3 records
Hudson Institute of Medical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hudson Institute of Medical Research leadership team
Management profileNumber of profiles
Hudson Institute of Medical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hudson Institute of Medical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hudson Institute of Medical Research
What does Hudson Institute of Medical Research do?
Hudson Institute of Medical Research is a not-for-profit medical research institute that conducts basic, translational, and clinical research focused on inflammation, cancer, and women's and newborn health. It operates a clinical trials centre, a translational research facility, and commercialises research outputs through licensing and industry partnerships. The institute was formed through the 2014 merger of the Monash Institute of Medical Research and Prince Henry's Institute.
Is Hudson Institute of Medical Research a public or private company?
Hudson Institute of Medical Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Hudson Institute of Medical Research founded?
Hudson Institute of Medical Research was founded in 2014. It employs 251 to 500 people.
Where is Hudson Institute of Medical Research based?
Hudson Institute of Medical Research is headquartered in Clayton, Australia, in the Oceania region.
How does Hudson Institute of Medical Research make money?
Three revenue lines are on record. Research Grants and Funding is the primary driver. The others are philanthropic Donations and commercialisation and Licensing.
Who are Hudson Institute of Medical Research's main competitors?
Direct peers on record are Peter MacCallum Cancer Centre, Garvan Institute of Medical Research, QIMR Berghofer Medical Research Institute, Harry Perkins Institute of Medical Research, South Australian Health and Medical Research Institute (SAHMRI), Walter and Eliza Hall Institute of Medical Research (WEHI), Baker Heart and Diabetes Institute, Doherty Institute for Infection and Immunity and Centenary Institute. Children's Medical Research Institute (CMRI) is listed as an emerging player.
Does Hudson Institute of Medical Research have an API?
No public API is recorded for Hudson Institute of Medical Research.
What industry is Hudson Institute of Medical Research in?
Hudson Institute of Medical Research's product category is Medical Research. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of HLAFAAAA, Academic Medical Centers (AMCs) & Teaching Hospitals. Its NAICS code is 541714 and its SIC code is 8731.